Avantor (NYSE:AVTR) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Avantor (NYSE:AVTR) released its quarterly earnings results on Friday. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.02, Briefing.com reports. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.68 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The business’s revenue was down 5.6% on a year-over-year basis. During the same period last year, the business earned $0.29 EPS.

Avantor Stock Performance

AVTR traded down $1.21 on Friday, hitting $23.94. 14,185,165 shares of the company’s stock were exchanged, compared to its average volume of 4,145,237. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 1.00. The stock has a fifty day moving average of $25.08 and a two-hundred day moving average of $22.61. Avantor has a twelve month low of $16.63 and a twelve month high of $26.16. The firm has a market cap of $16.24 billion, a PE ratio of 49.88, a P/E/G ratio of 2.56 and a beta of 1.37.

Insider Buying and Selling at Avantor

In related news, EVP James Bramwell sold 6,203 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the completion of the transaction, the executive vice president now directly owns 101,143 shares in the company, valued at approximately $2,476,992.07. The sale was disclosed in a document filed with the SEC, which is available through this link. 1.50% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. UBS Group raised their target price on Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, February 15th. Raymond James raised their price objective on Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a research note on Friday, January 26th. Deutsche Bank Aktiengesellschaft upped their target price on Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research report on Thursday, April 18th. Robert W. Baird increased their target price on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Thursday, February 15th. Finally, Citigroup lifted their price target on shares of Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a research note on Thursday, February 15th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Avantor has a consensus rating of “Moderate Buy” and a consensus price target of $26.71.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.